IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
- Status
- COMPLETED
- Phase
- PHASE1
PD-L1 Expression in Japanese Renal Cell Carcinoma Patients
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.
- Status
- COMPLETED
- Phase
- N/A
3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement
- Status
- UNKNOWN
- Phase
- NA
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
- Status
- TERMINATED
- Phase
- PHASE3
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
- Status
- TERMINATED
- Phase
- N/A
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC
- Status
- COMPLETED
- Phase
- N/A
A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- NA
ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)
- Status
- COMPLETED
- Phase
- PHASE2
Surgical Treatment of Pancreatic RCC Metastases
- Status
- COMPLETED
- Phase
- N/A
Non-Invasive Diagnostics of Small Renal Masses
- Status
- UNKNOWN
- Phase
- N/A
A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread
- Status
- COMPLETED
- Phase
- N/A
APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A